Loading
ME Therapeutics Holdings Inc. Stock: price and insider trades · Canada
CA·Mcap CA$54.1M
ME Therapeutics Holdings Inc.: what insiders have been doing
ME Therapeutics Holdings Inc. is a listed company. Its insiders report their share dealings to SEDI. In the past year (17 October 2025 to 17 October 2026), 16 filings came from 7 insiders.
The flow runs one way only: 1 insider bought (2 purchases totalling €371) and nobody sold on the market. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Dhanji, Rahim filed the largest purchase, €246, on 30 June 2026, which represents 0.0009% of the company's market value. The buyers include 1 major shareholder.
The clock since the last published purchase (9 October 2026) now reads 8 days. The median gap between a trade and its publication by SEDI is 1 day. Until a filing is published, the market cannot know about the trade.
Across the 2,144 companies tracked on its exchange, the median is 12 filings; at 16 filings, this issuer sits above that mark. The full history, which starts in 2026, counts 2 purchases against no sales.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Insider Decl.
16
Thresholds
n/a
Buy Volume
€371
2 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleRahim Dhanji2 buys
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended August 2025 · cache
CA$1.80
Analyst consensus
Income statement
EBITDA-CA$1.1M
Net income-CA$1.2M0.0% margin
Valuation
P/Book85.7x
Beta-0.01
Balance sheet & cash
Market capCA$54.1M
Total debtCA$71.7k
Free Cash Flow-CA$1.1M
Debt / Equity4%
Profitability & ownership
ROE-111.0%
ROA-69.0%
% insiders55.4%
% institutions0.0%
Last declaration on 9 October 2026
Declarations16 total
100 shares@ CA$2.000.0002% mcap33.7% of flowCommon SharesTSXSEDI:4789890
Canonical exit: 5 Jan 2027 (T+90)
294,118 shares@ CA$2.001.40% mcap37.1% of flowWarrantsTSXSEDI:4753264
294,118 shares@ CA$1.701.19% mcap31.5% of flowCommon SharesTSXSEDI:4753262
250,000 shares@ CA$1.991.18% mcap31.4% of flowOptionsTSXSEDI:4753260
800,000 shares@ CA$1.993.79% mcap100.0% of flowOptionsTSXSEDI:4753258
250,000 shares@ CA$1.991.18% mcap100.0% of flowOptionsTSXSEDI:4753130
250,000 shares@ CA$1.991.18% mcap100.0% of flowOptionsTSXSEDI:4753122
250,000 shares@ CA$1.991.18% mcap100.0% of flowOptionsTSXSEDI:4753073
125,000 shares@ CA$1.990.59% mcap100.0% of flowOptionsTSXSEDI:4753050
250,000 sharesOptionsTSXSEDI:4751442
125,000 sharesOptionsTSXSEDI:4749461
250,000 sharesOptionsTSXSEDI:4748853
250,000 sharesOptionsTSXSEDI:4748848
250,000 sharesOptionsTSXSEDI:4748841
800,000 sharesOptionsTSXSEDI:4748818
200 shares@ CA$1.990.0009% mcap100.0% of flowCommon SharesTSXSEDI:4741838
Canonical exit: 27 Sept 2026 (T+90)
16 of 16 declarations
About ME Therapeutics Holdings Inc.
ME Therapeutics Holdings Inc. is a company listed on the Toronto Stock Exchange, specializing in the development of innovative therapies. It focuses on enhancing medical treatments through biotechnology-based approaches.
